Sangamo Therapeutics
SGMO
#8167
Rank
โ‚น17.79 B
Marketcap
โ‚น85.31
Share price
2.40%
Change (1 day)
-8.07%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น6.28 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are โ‚น6.28 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น6.86 B-69%
2022-12-31โ‚น22.13 B-14.17%
2021-12-31โ‚น25.79 B-20.05%
2020-12-31โ‚น32.26 B120.95%
2019-12-31โ‚น14.60 B-6.41%
2018-12-31โ‚น15.60 B147.22%
2017-12-31โ‚น6.31 B328.06%
2016-12-31โ‚น1.47 B-10.53%
2015-12-31โ‚น1.64 B-28.92%
2014-12-31โ‚น2.31 B96.18%
2013-12-31โ‚น1.18 B22.37%
2012-12-31โ‚น0.96 B153.4%
2011-12-31โ‚น0.38 B19.92%
2010-12-31โ‚น0.31 B-56.26%
2009-12-31โ‚น0.72 B21.36%
2008-12-31โ‚น0.59 B29.5%
2007-12-31โ‚น0.46 B47.51%
2006-12-31โ‚น0.31 B-37.65%
2005-12-31โ‚น0.50 B394.27%
2004-12-31โ‚น0.10 B42.16%
2003-12-31โ‚น71.52 M-24.71%
2002-12-31โ‚น94.99 M-26.21%
2001-12-31โ‚น0.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น3.148 T 49,997.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น363.61 B 5,685.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.490 T 119,078.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น987.56 B 15,612.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.438 T 54,608.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น9.464 T 150,482.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น125.28 B 1,893.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.358 T 101,068.74%๐Ÿ‡บ๐Ÿ‡ธ USA